These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 34485905)

  • 21. Altered alpha and theta oscillations correlate with sequential working memory in Parkinson's disease.
    Ye Z; Heldmann M; Herrmann L; Brüggemann N; Münte TF
    Brain Commun; 2022; 4(3):fcac096. PubMed ID: 35755636
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dopamine is associated with prioritization of reward-associated memories in Parkinson's disease.
    Sharp ME; Duncan K; Foerde K; Shohamy D
    Brain; 2020 Aug; 143(8):2519-2531. PubMed ID: 32844197
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Gray and White Matter Contributions to Cognitive Frontostriatal Deficits in Non-Demented Parkinson's Disease.
    Price CC; Tanner J; Nguyen PT; Schwab NA; Mitchell S; Slonena E; Brumback B; Okun MS; Mareci TH; Bowers D
    PLoS One; 2016; 11(1):e0147332. PubMed ID: 26784744
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Reward and Punishment Learning as Predictors of Cognitive Behavioral Therapy Response in Parkinson's Disease Comorbid with Clinical Depression.
    Perskaudas R; Myers CE; Interian A; Gluck MA; Herzallah MM; Baum A; Dobkin RD
    J Geriatr Psychiatry Neurol; 2024 Jul; 37(4):282-293. PubMed ID: 38158704
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Compensatory fronto-parietal hyperactivation during set-shifting in unmedicated patients with Parkinson's disease.
    Gerrits NJ; van der Werf YD; Verhoef KM; Veltman DJ; Groenewegen HJ; Berendse HW; van den Heuvel OA
    Neuropsychologia; 2015 Feb; 68():107-16. PubMed ID: 25576907
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Neural correlates of working memory and compensation at different stages of cognitive impairment in Parkinson's disease.
    Hattori T; Reynolds R; Wiggs E; Horovitz SG; Lungu C; Chen G; Yasuda E; Hallett M
    Neuroimage Clin; 2022; 35():103100. PubMed ID: 35780660
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Impaired context-sensitive adjustment of behaviour in Parkinson's disease patients tested on and off medication: An fMRI study.
    Trempler I; Bürkner PC; El-Sourani N; Binder E; Reker P; Fink GR; Schubotz RI
    Neuroimage; 2020 May; 212():116674. PubMed ID: 32097724
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Exercise- and strategy-based physiotherapy-delivered intervention for preventing repeat falls in people with Parkinson's: the PDSAFE RCT.
    Ashburn A; Pickering R; McIntosh E; Hulbert S; Rochester L; Roberts HC; Nieuwboer A; Kunkel D; Goodwin VA; Lamb SE; Ballinger C; Seymour KC
    Health Technol Assess; 2019 Jul; 23(36):1-150. PubMed ID: 31339100
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The structural connectivity of discrete networks underlies impulsivity and gambling in Parkinson's disease.
    Mosley PE; Paliwal S; Robinson K; Coyne T; Silburn P; Tittgemeyer M; Stephan KE; Breakspear M; Perry A
    Brain; 2019 Dec; 142(12):3917-3935. PubMed ID: 31665241
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Different patterns of short-term memory deficit in Alzheimer's disease, Parkinson's disease and subjective cognitive impairment.
    Zokaei N; Sillence A; Kienast A; Drew D; Plant O; Slavkova E; Manohar SG; Husain M
    Cortex; 2020 Nov; 132():41-50. PubMed ID: 32919108
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Ageing and early-stage Parkinson's disease affect separable neural mechanisms of mesolimbic reward processing.
    Schott BH; Niehaus L; Wittmann BC; Schütze H; Seidenbecher CI; Heinze HJ; Düzel E
    Brain; 2007 Sep; 130(Pt 9):2412-24. PubMed ID: 17626038
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Systemic sulpiride in young adult volunteers simulates the profile of cognitive deficits in Parkinson's disease.
    Mehta MA; Sahakian BJ; McKenna PJ; Robbins TW
    Psychopharmacology (Berl); 1999 Sep; 146(2):162-74. PubMed ID: 10525751
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Functional brain activity and presynaptic dopamine uptake in patients with Parkinson's disease and mild cognitive impairment: a cross-sectional study.
    Ekman U; Eriksson J; Forsgren L; Mo SJ; Riklund K; Nyberg L
    Lancet Neurol; 2012 Aug; 11(8):679-87. PubMed ID: 22742929
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Neural correlates of early cognitive dysfunction in Parkinson's disease.
    Weil RS; Winston JS; Leyland LA; Pappa K; Mahmood RB; Morris HR; Rees G
    Ann Clin Transl Neurol; 2019 May; 6(5):902-912. PubMed ID: 31139688
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Eye movement parameters and cognitive functions in Parkinson's disease patients without dementia.
    Wong OW; Chan AY; Wong A; Lau CK; Yeung JH; Mok VC; Lam LC; Chan S
    Parkinsonism Relat Disord; 2018 Jul; 52():43-48. PubMed ID: 29571955
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Disturbed functional brain interactions underlying deficient tactile object discrimination in Parkinson's disease.
    Weder B; Azari NP; Knorr U; Seitz RJ; Keel A; Nienhusmeier M; Maguire RP; Leenders KL; Ludin HP
    Hum Brain Mapp; 2000 Nov; 11(3):131-45. PubMed ID: 11098793
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Neurofunctional characteristics of executive control in older people with HIV infection: a comparison with Parkinson's disease.
    Müller-Oehring EM; Hong JY; Poston KL; Brontë-Stewart HM; Sullivan EV; McGlynn L; Schulte T
    Brain Imaging Behav; 2022 Aug; 16(4):1776-1793. PubMed ID: 35294979
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical implications for dopaminergic and functional neuroimage research in cognitive symptoms of Parkinson's disease.
    Hirano S
    Mol Med; 2021 Apr; 27(1):40. PubMed ID: 33858320
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Locus Coeruleus Integrity Is Linked to Response Inhibition Deficits in Parkinson's Disease and Progressive Supranuclear Palsy.
    Ye R; Hezemans FH; O'Callaghan C; Tsvetanov KA; Rua C; Jones PS; Holland N; Malpetti M; Murley AG; Barker RA; Williams-Gray CH; Robbins TW; Passamonti L; Rowe JB
    J Neurosci; 2023 Oct; 43(42):7028-7040. PubMed ID: 37669861
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cholinesterase inhibitors for dementia with Lewy bodies, Parkinson's disease dementia and cognitive impairment in Parkinson's disease.
    Rolinski M; Fox C; Maidment I; McShane R
    Cochrane Database Syst Rev; 2012 Mar; 2012(3):CD006504. PubMed ID: 22419314
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.